Estimating Hypothetically Negotiated Royalty Rates After MedImmune, Inc. v Genentech, Inc. et al
$25.00v14i3: pp. 43-52 Stenan D. Porter Antitrust 2008
Showing the single result
Showing the single result
v14i3: pp. 43-52 Stenan D. Porter Antitrust 2008
Book Review: Illiberal Reformers
1 × $25.00 Valuing a non-publicly-traded business: A review and update
1 × $25.00 Credit Expectancy Damages – A New Six Figure Hedonic Bonanza?
1 × $25.00 Estimating Hypothetically Negotiated Royalty Rates After MedImmune, Inc. v Genentech, Inc. et al
1 × $25.00 A nontrivial (though seemingly not uncommon) error in calculating the discount rate used to reduce future losses to present value
1 × $25.00 Subtotal: $125.00